Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Patients with Hematologic Malignancy

Infections with extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli are common in patients with hematologic malignancy. The utility of cefepime and piperacillin-tazobactam as empiric therapy for ESBL-producing E. coli bacteremia in patients with hematologic malignancy is largely unknown....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Antimicrob Agents Chemother
Главные авторы: Benanti, Grace E., Brown, Anne Rain T., Shigle, Terri Lynn, Tarrand, Jeffrey J., Bhatti, Micah M., McDaneld, Patrick M., Shelburne, Samuel A., Aitken, Samuel L.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2019
Предметы:
Clinical Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355563/
https://ncbi.nlm.nih.gov/pubmed/30509935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01813-18
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы